BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Evotec AG Raises $40 Million From Biotechnology Value Fund; Stock Up +10.60% at Market Close (September 3, 2013)

  September 3, 2013

   · 

  4 min read
• Drug Development

  Teva Pharmaceutical Industries Limited to Drop Depression Treatment After Phase 3 Trial Fails

  September 3, 2013

   · 

  6 min read
• Business

  Solta Medical, Inc. Seeks Help to Lead CEO Search

  September 3, 2013

   · 

  3 min read
• Business

  Philips Healthcare, Johnson & Johnson Land U.S. Department of Defense Contracts Worth Up to $73 Million

  September 3, 2013

   · 

  1 min read
• Genetown

  Safeguard Scientifics Backs Med-Tech Company Quantia With $7.5 Million

  September 3, 2013

   · 

  5 min read
• Pharm Country

  Struggling Mela Sciences Receives De-Listing Notice From NASDAQ

  September 3, 2013

   · 

  1 min read
• BioMidwest

  Medtronic, Inc. Launches New Health Services Arm

  September 3, 2013

   · 

  4 min read
• Business

  New Seattle Biopharmaceutical Company Formed, Rain BioScience

  September 3, 2013

   · 

  1 min read
• Drug Development

  Amgen, Cytokinetics, Inc. Heart Failure Drug Misses Phase 2 Goals; CYTK Stock Plummets -27.13% at Market Close (September 3, 2013)

  September 3, 2013

   · 

  14 min read
• Drug Development

  TRANSGENE’s TRAVERSE Phase 2 Study Fails to Meet Main Goal

  September 3, 2013

   · 

  5 min read